5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic

CAS : 74103-06-3

Ref. 3D-IB58062

Informations sur le produit

• Nom: 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic
• Marque: Biosynth
• Description: 5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic (5BPC) is a drug that is used for the treatment of pain. It has been shown to be safe and effective in treating postoperative pain when given by intravenous infusion or as an oral tablet. 5BPC has minimal toxicity and is metabolized primarily by the liver with a half life of 2.6 hours. The drug has been found to have pharmacokinetic properties that allow it to be used safely in patients with hepatic impairment and in those recovering from abdominal surgery. 5BPC is a prodrug that undergoes biotransformation by esterases into its active form, pyrrolizidine alkaloid (PA). PA acts as a nonsteroidal anti-inflammatory agent and inhibits prostaglandin synthesis, which leads to analgesia. This drug also has minimal drug interactions because

Propriétés chimiques

• Masse moléculaire: 255.27 g/mol
• Formule: C₁₅H₁₃O₃N
• Degré de pureté: Min. 95%